Global Bird Flu Market Size To Exceed USD 2.18 Billion By 2033 | CAGR of 4.53%
Category: HealthcareGlobal Bird Flu Market Size To Exceed USD 2.18 Billion By 2033
According to a research report published by Spherical Insights & Consulting, the Global Bird Flu Market Size Expected to Grow from USD 1.40 Billion in 2023 to USD 2.18 Billion by 2033, at a CAGR of 4.53% during the forecast period 2023-2033.
Get more details on this report -
Browse key industry insights spread across 237 pages with 120 Market data tables and figures & charts from the report on the "Global Bird Flu Market Size, Share, and COVID-19 Impact Analysis, By Virus Type (H5N1, H7N9, H5N6, H5N8, H10N8, H9N2, and Others), By Test Type (PCR Tests, ELISA Tests, Hemagglutination Assays, Virus Isolation Tests, Next Generation Sequencing, and Others), By Treatment Type (Vaccines, Antiviral Medication, Immunomodulators, and Others), By Animal Type (Chickens, Ducks, Geese & Swans, Pigeons, Guinea Fowls, Turkeys, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/bird-flu-market
Bird flu is a viral infection produced by avian influenza viruses that primarily affects birds but can be transmitted to humans and other animals. The global bird flu market includes products, services, and technology that can be used to prevent, diagnose, manage, and treat avian influenza, also known as bird flu. Opportunities in the avian flu industry stem from advances in vaccine technology, particularly instant-response mechanisms such as mRNA vaccines. Government expenditures in vaccine stocks and preparedness programs represent distinct development potential in the US and Europe. The bird flu industry is being driven by rising government expenditure in vaccine research, notably for mRNA technologies, as well as a growing requirement for pandemic preparedness because of the possibility of avian influenza outbreaks. However, restrictions in the bird flu market include a lack of funding for widespread vaccine distribution, which impedes global vaccination initiatives. Vaccine approval policies differ significantly among countries, limiting vaccine dissemination.
The H5N1 segment is expected to hold the largest share of the global bird flu market during the projected timeframe.
Based on the virus type, the global bird flu market is categorized as H5N1, H7N9, H5N6, H5N8, H10N8, H9N2, and others. Among these, the H5N1 segment is expected to hold the largest share of the global bird flu market during the projected timeframe. This is because to its previous significant influence on both human and avian populations, for which it is still being monitored and vaccines developed. The H5N1 virus is a concern that requires ongoing attention because it has the potential to trigger pandemics if it acquires mutations that allow it to be easily transmitted among humans.
The next generation sequencing segment is expected to grow at the fastest CAGR during the projected timeframe.
Based on the test type, the global bird flu market is categorized as PCR tests, ELISA tests, hemagglutination assays, virus isolation tests, next generation sequencing, and others. Among these, the next generation sequencing segment is expected to grow at the fastest CAGR during the projected timeframe. It has excellent capabilities for doing rapid and accurate genomic analysis, with NGS highlighting the alterations that viruses go through to aid in early detection and surveillance.
The vaccines segment is expected to hold the largest share of the global bird flu market during the projected timeframe.
Based on treatment type, the global bird flu market is categorized as vaccines, antiviral medication, immunomodulators, and others. Among these, the vaccines segment is expected to hold the largest share of the global bird flu market during the projected timeframe. This is because such vaccines are crucial in preventing the spread of avian flu, especially in high-risk locations. The international health community and governments are interested in vaccine development as a way to contain rapid epidemics.
The chicken’s segment is expected to grow at the fastest CAGR during the projected timeframe.
Based on the animal type, the global bird flu market is categorized as chickens, ducks, geese & swans, pigeons, guinea fowls, turkeys, and others. Among these, the chicken’s segment is expected to grow at the fastest CAGR during the projected timeframe. Chicken is also the most commonly reported poultry bird species in outbreaks, making it the top priority to monitor for vaccination and management. As chicken is widely raised in commercial and small farms around the world, this has an important financial effect.
Asia Pacific is projected to hold the largest share of the global bird flu market over the projected timeframe.
Asia Pacific is projected to hold the largest share of the global bird flu market over the projected timeframe. This is partly because outbreaks of avian influenza are widespread in most nations, especially China, India, and Indonesia, due to the significance of the poultry business. Additionally, the region's large chicken population and government initiatives into vaccine programs.
North America is expected to grow at the fastest CAGR growth of the global bird flu market during the projected timeframe. This growth is a consequence of continued monitoring and control efforts, particularly in the United States and Canada, where chicken farming is a high-profile sector. Government agencies, such as the United States Department of Agriculture (USDA), are largely focused on the readiness for avian influenza epidemics, with significant investments in surveillance systems and vaccine development.
Major vendors in the global bird flu market are Ceva Sante Animale, Zoetis, Merck & Co., Ringpu Biology, Yebio Bioengineering, FATRO, CAVAC, ChengDu Tecbond, QYH Biotech, Elanco, Phibro Animal Health, Vetoquinol, Hipra, Anicon Labor GmbH, and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Developments
- In September 2023, Wageningen Bioveterinary Research (WBVR) started an experiment with bird flu vaccine. The trial tests vaccines against the current H5 viruses on laying hens. This initial immunization experiment is carried out in the animal facilities of WBVR's high containment unit. The current immunizations were developed by three different pharmaceutical companies, and the tested vaccines employ a variety of technologies.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global bird flu market based on the below-mentioned segments:
Global Bird Flu Market, By Virus Type
- H5N1
- H7N9
- H5N6
- H5N8
- H10N8
- H9N2
- Others
Global Bird Flu Market, By Test Type
- PCR Tests
- ELISA Tests
- Hemagglutination Assays
- Virus Isolation Tests
- Next Generation Sequencing
- Others
Global Bird Flu Market, By Treatment Type
- Vaccines
- Antiviral Medication
- Immunomodulators
- Others
Global Bird Flu Market, By Animal Type
- Chickens
- Ducks
- Geese & Swans
- Pigeons
- Guinea Fowls
- Turkeys
- Others
Global Bird Flu Market, By Regional
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?